SS-31 Dosage Guide
Clinical Trials
Written by Alejandro Reyes
Founder & Lead Researcher
PN
Reviewed by Peptide Nerds Editorial · Updated April 2026
Not medical advice. Dosage information is provided for educational purposes based on published research.
Always consult a qualified healthcare provider before starting any protocol. Full disclaimer.
Dosage overview
| Typical dose | 0.25-5 mg daily |
| Frequency | Once daily |
Dosing notes
In clinical trials for Barth syndrome and heart failure.
Important safety information
Dosage ranges listed above are based on available research data and reported protocols. Individual dosing should be determined by a qualified healthcare provider based on your specific health profile, goals, and response to treatment.
- Start at the lowest effective dose and titrate up gradually
- Monitor for side effects, especially during dose increases
- Do not exceed researched dose ranges without medical supervision
Free Peptide Weight Loss Guide
Semaglutide vs. tirzepatide vs. retatrutide. Dosing protocols, side effects, gray market sourcing, and what the clinical trials found.